SCHEMBL7229230

SCHEMBL7229230

Cn1cc(C(=O)O)c(=O)c2cc3cc(F)c(N4CCN(Cc5ccccc5)CC4)cc3nc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.46
ALDH1A1 P00352 5/20 0.44
DRD3 P35462 1/20 0.44
KDM4E B2RXH2 6/20 0.43
LMNA P02545 3/20 0.43
HPGD P15428 3/20 0.43
HSD17B10 Q99714 2/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
POLB P06746 1/20 0.43
NCF1 P14598 1/20 0.42
TOP1 P11387 1/20 0.42
USP2 O75604 1/20 0.42
TSHR P16473 1/20 0.42
HTT P42858 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
OPRL1 P41146 1/20 0.42
PIK3CG P48736 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7227506 0.94 LMNA (0.47) HRH3ALDH1A1DRD3KDM4ELMNA
SCHEMBL9775938 0.88 ALDH1A1 (0.55) ALDH1A1DRD3KDM4ELMNAHPGD
SCHEMBL9775903 0.87 ALDH1A1 (0.46) HRH3ALDH1A1DRD3KDM4ELMNA
SCHEMBL9094359 0.86 ALDH1A1 (0.55) HRH3ALDH1A1DRD3KDM4ELMNA
Hydrochloric Acid SCHEMBL9097124 0.85 ALDH1A1 (0.54) HRH3ALDH1A1DRD3KDM4ELMNA
SCHEMBL9786221 0.85 ALDH1A1 (0.47) ALDH1A1DRD3KDM4ELMNAHPGD
SCHEMBL7228568 0.84 ALDH1A1 (0.45) ALDH1A1DRD3KDM4ELMNAHPGD
SCHEMBL7229082 0.84 KDM4E (0.50) HRH3ALDH1A1DRD3KDM4ELMNA
SCHEMBL6603300 0.84 LMNA (0.55) ALDH1A1DRD3KDM4ELMNAHPGD
SCHEMBL7228493 0.83 KMT2A (0.41) ALDH1A1DRD3KDM4ELMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6548506-B2 1-substituted,3-carboxy,7-fluoro,8-disubstituted amino-1,4-dihydrobenzo(b)(1,8)naphthyridin-4-ones; Useful as antimicrobial agents; topical antibiotic for wounds AVENTIS PHARMA S.A. (FR) 2003-04-15 US disclosed
US-20020037891-A1 Novel benzo[1,8]naphthyridine derivatives, their preparation and pharmaceutical compositions which comprise them AVENTIS PHARMA S.A. (FR) 2002-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020037891-A1 Novel benzo[1,8]naphthyridine derivatives, their preparation and pharmaceutical compositions which comprise them ABCB11, NDUFA9, NDUFC1 HRH3 3098/4885ALDH1A1 672/4885DRD3 2525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.